Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.89M Buy
21,039
+5,480
+35% +$773K 1.62% 14
2026
Q2
$2.28M Buy
15,559
+7,724
+99% +$1.4M 1.31% 14
2026
Q1
$1.15M Buy
7,835
+2,770
+55% +$450K 0.76% 35
2025
Q4
$987K Buy
5,065
+4,000
+376% +$952K 0.67% 39
2025
Q3
$300K Buy
1,065
+90
+9% +$22.9K 0.21% 133
2025
Q2
$213K Buy
+975
New +$157K 0.17% 160

Other funds holding ORCL

M.E. Allison & Co's ORCL Position: Q3 2026 in Review

M.E. Allison & Co increased its Oracle (ORCL) stake by 35% in Q3 2026, buying an estimated $773K and bringing the position to 21,039 shares worth $2.89M. The position accounts for 1.62% of the portfolio, ranked #14.

M.E. Allison & Co first reported a position in ORCL in Q2 2025 and has held it in 6 quarters since. 779 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • M.E. Allison & Co held 21,039 shares of Oracle worth $2.89M as of Q3 2026.
  • M.E. Allison & Co bought 5,480 Oracle shares in Q3 2026, an estimated $773K.
  • Oracle made up 1.62% of M.E. Allison & Co's portfolio in Q3 2026, its #14 holding.
  • M.E. Allison & Co first reported a position in Oracle in Q2 2025 and has held it in 6 quarters since.
  • 779 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.